Clinical trial
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid…
NCT00002517 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00002517 |
|---|---|
| Title | Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome |
| Official title | IDA VS MTZ IN INDUCTION AND INTENSIFICATION TREATMENT OF AML OR MDS IN CHILDREN, A PHASE III RANDOMIZED STUDY |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia, Myelodysplastic Syndromes |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | cytarabine, daunorubicin hydrochloride, dexamethasone, etoposide, idarubicin, mitoxantrone hydrochloride, thioguanine, allogeneic bone marrow transplantation, radiation therapy |
| Start date | Mar 1, 1993 |
| Primary completion | May 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 22, 2010 |
| Countries | Belgium, France, Portugal |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: